Cardiocast

Analysis shows ‘Devil’s bargain’ in cardiac arrest


 

The “Devil’s bargain” of epinephrine use in cardiac arrest plays out in a new analysis. Also this week, updated recommendations reflect maturation of transcatheter aortic valve replacement, a comparison of cardiovascular protection in type 2 diabetes drugs, and sweeping reductions in documentation requirements headline a new Medicare fee schedule proposal. Listen on iTunes.

Recommended Reading

More from EuroPCR and Heart Rhythm
MDedge Family Medicine
NIH cans study that relied on millions in funding from alcohol companies
MDedge Family Medicine
MI risk prediction after noncardiac surgery simplified
MDedge Family Medicine
Alirocumab’s benefit greater in diabetes patients: ODYSSEY Outcomes
MDedge Family Medicine
New look at ATLAS suggests rivaroxaban may still have role in ACS
MDedge Family Medicine
DOJ lawsuit reins in inappropriate ICD use
MDedge Family Medicine
Alteplase, aspirin provide similar functional outcomes after nondisabling stroke
MDedge Family Medicine
Obesity triples post-MI sudden cardiac death risk
MDedge Family Medicine
Older black patients die sooner after in-hospital cardiac arrest
MDedge Family Medicine
Medicare’s bundled pay plan didn’t deliver big cost savings
MDedge Family Medicine